Related Experiment Video
Updated: Dec 5, 2025

13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
14.3K
Determining Reference Ranges for Total T4 in Dried Blood Samples for Newborn Screening.
Anna-Isabella Hijman1, Daniel Konrad2, Ralph Fingerhut3
1University Children's Hospital Zurich, 8032 Zurich, Switzerland.
International Journal of Neonatal Screening
|October 19, 2020
Summary
This study establishes reference intervals for total thyroxine (tT4) in dried blood spots for newborn screening. Age-specific ranges are crucial for premature infants, while a single range suffices for term-born infants.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Clinical Chemistry
Background:
- Newborn screening programs rely on accurate biochemical markers.
- Total thyroxine (tT4) is a key thyroid hormone measured in neonatal screening.
- Establishing reliable reference intervals in dried blood spots (DBSs) is essential for accurate interpretation.
Purpose of the Study:
- To define reference intervals for tT4 in DBSs for newborn screening.
- To assess the utility of direct tT4 measurement in DBSs for premature and term-born infants.
- To determine if gestational age-specific reference ranges are necessary.
Main Methods:
- Retrospective analysis of tT4 concentrations in DBSs collected over 21 weeks.
- Inclusion of premature infants (<30 weeks gestational age) and term-born infants.
- Assessment of tT4 stability in DBSs to determine appropriate sample collection timeframes.
Main Results:
- A strong correlation was observed between tT4 levels and gestational age in premature infants.
- This correlation necessitates the development of age-specific reference ranges for premature neonates.
- For term-born infants, tT4 ranges showed no significant variation with gestational age, supporting a single reference range.
Conclusions:
- Gestational age-specific reference intervals for tT4 in DBSs are vital for accurate assessment of premature infants.
- A universal reference interval for tT4 in DBSs is applicable to term-born infants.
- Direct measurement of tT4 in DBSs can be a valuable tool in neonatal screening, with tailored reference ranges.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
91
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
91
Therapeutic Drug Monitoring: Affecting Factors
102
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
102
Synthesis and Regulation of Thyroid Hormones
6.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.6K

